Paul Tudor Jones Medical Devices

Tudor Investment Corp Et Al

$29 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$150B	$25.8 Million 0.09% of portfolio	256,131	Q1 2025 New
SYK Stryker Corp	$147B	$10.9 Million 0.04% of portfolio	29,358	Q1 2025 Added 56.2%
BRKR Bruker Corp	$6.25B	$8.6 Million 0.03% of portfolio	205,962	Q1 2025 New
EW Edwards Lifesciences Corp	$47.1B	$8.34 Million 0.03% of portfolio	115,014	Q1 2025 New
TNDM Tandem Diabetes Care Inc	$986M	$7.77 Million 0.03% of portfolio	405,292	Q1 2025 Added 139.76%
LIVN Liva Nova PLC	$2.28B	$7.44 Million 0.03% of portfolio	189,316	Q1 2025 Added 38.85%
TMDX Trans Medics Group, Inc.	$3.58B	$7.05 Million 0.02% of portfolio	104,826	Q1 2025 New
GMED Globus Medical Inc	$4.43B	$6.59 Million 0.02% of portfolio	90,000	Q1 2025 Reduced 15.11%
AORT Artivion, Inc.	$1.24B	$5.78 Million 0.02% of portfolio	234,989	Q1 2025 Added 32.72%
ATEC Alphatec Holdings, Inc.	$1.11B	$4.24 Million 0.01% of portfolio	417,666	Q1 2025 Reduced 28.71%
LNSR Lensar, Inc.	$146M	$3.91 Million 0.01% of portfolio	277,002	Q1 2025 New
FNA Paragon 28, Inc.	$1B	$3.54 Million 0.01% of portfolio	270,776	Q1 2025 Added 399.55%
BFLY Butterfly Network, Inc.	$320M	$3.32 Million 0.01% of portfolio	1,457,243	Q1 2025 Added 64.67%
OFIX Orthofix Medical Inc.	$217M	$2.95 Million 0.01% of portfolio	180,567	Q1 2025 Added 35.23%
TMCI Treace Medical Concepts, Inc.	$321M	$2.88 Million 0.01% of portfolio	343,490	Q1 2025 Added 57.79%
BVS Bioventus Inc.	$400M	$2.21 Million 0.01% of portfolio	241,391	Q1 2025 Added 14.24%
RXST Rx Sight, Inc.	$204M	$2.2 Million 0.01% of portfolio	87,304	Q1 2025 Added 28.13%
AXGN Axogen, Inc.	$492M	$2.01 Million 0.01% of portfolio	108,739	Q1 2025 Added 24.2%
IART Integra Lifesciences Holdings Corp	$1B	$1.76 Million 0.01% of portfolio	79,927	Q1 2025 Reduced 61.59%
UFPT Ufp Technologies Inc	$1.76B	$1.74 Million 0.01% of portfolio	8,641	Q1 2025 New
MDT Medtronic PLC	$119B	$1.62 Million 0.01% of portfolio	18,037	Q1 2025 Reduced 83.59%
CLPT Clear Point Neuro, Inc.	$279M	$1.53 Million 0.01% of portfolio	128,698	Q1 2025 New
SMLR Semler Scientific, Inc.	$297M	$1.45 Million 0.0% of portfolio	39,985	Q1 2025 New
CVRX Cv Rx, Inc.	$172M	$1.44 Million 0.0% of portfolio	118,026	Q1 2025 Added 55.53%
LUNG Pulmonx Corp	$115M	$1.38 Million 0.0% of portfolio	204,818	Q1 2025 Added 37.37%
IRMD Iradimed Corp	$722M	$1.23 Million 0.0% of portfolio	23,467	Q1 2025 Reduced 24.34%
INGN Inogen Inc	$153M	$1.15 Million 0.0% of portfolio	161,174	Q1 2025 Added 94.53%
VREX Varex Imaging Corp	$313M	$885,000 0.0% of portfolio	76,335	Q1 2025 Added 57.55%
ZIMV Zim Vie Inc.	$267M	$785,000 0.0% of portfolio	72,702	Q1 2025 Reduced 25.46%
AVNS Avanos Medical, Inc.	$541M	$691,000 0.0% of portfolio	48,281	Q1 2025 Added 48.23%
NVRO Nevro Corp	$207M	$595,000 0.0% of portfolio	101,919	Q1 2025 Reduced 21.67%
NPCE Neuro Pace Inc	$226M	$590,000 0.0% of portfolio	48,010	Q1 2025 New
ARAY Accuray Inc	$127M	$378,000 0.0% of portfolio	211,597	Q1 2025 Added 95.27%
SIBN Si Bone, Inc.	$574M	$241,000 0.0% of portfolio	17,224	Q1 2025 Reduced 80.65%
ALGN Align Technology Inc	$15B	$217,000 0.0% of portfolio	1,366	Q1 2025 New
ANIK Anika Therapeutics, Inc.	$164M	$204,000 0.0% of portfolio	13,628	Q1 2025 Reduced 62.13%
SENS Senseonics Holdings, Inc.	$261M	$115,000 0.0% of portfolio	174,383	Q4 2022 Reduced 3.82%

Shares Options

Paul Tudor Jones

Paul Tudor Jones is the founder and CEO of Tudor Investment Corp, a successful investment firm that focuses on macro investing. Jones is known for his expertise in macro investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Paul Tudor Jones's portfolio

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account